Easywell Biomedicals, Inc. (TPEX:1799)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
32.50
+0.05 (0.15%)
Jul 30, 2026, 9:54 AM CST

Easywell Biomedicals Balance Sheet

Millions TWD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
323.29281.06325.67262.91159.03153.03
Short-Term Investments
130.27130.2120.2785.12180.51271.24
Trading Asset Securities
-40.4320.16--15.01
Cash & Short-Term Investments
453.57451.69466.1348.03339.54439.28
Cash Growth
-2.75%-3.09%33.92%2.50%-22.71%90.50%
Accounts Receivable
61.5439.1342.4566.9320.4830.58
Other Receivables
25.7926.8815.511.383.523.23
Receivables
87.3266.0157.9668.3123.9933.82
Inventory
158.96158.54259.2642.1726.8320.55
Prepaid Expenses
18.7223.7834.8849.1222.0916.45
Total Current Assets
718.57700.01818.2507.64412.44510.09
Property, Plant & Equipment
481.13487.21545.49542.2572.71555.54
Long-Term Investments
44.870.060.060.060.06-
Other Intangible Assets
89.37101.24136.52156.1168.44179.84
Other Long-Term Assets
4.353.785.047.819.518.44
Total Assets
1,3381,2921,5051,2141,1731,264

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
29.058.2245.639.422.360.47
Short-Term Debt
92.5889.92201.0943.27--
Current Portion of Leases
26.0824.4920.7312.6311.479.86
Current Unearned Revenue
61.0368.533.7439.834.1911.75
Other Current Liabilities
84.8287.11122.5122.4516.114.11
Total Current Liabilities
293.56278.23423.71127.5764.1136.18
Long-Term Leases
311.57311.51342.46330.45338.48315.64
Other Long-Term Liabilities
---131.97--
Total Liabilities
605.13589.74766.17589.99402.6351.82

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
1,2471,2471,2181,1591,1441,634
Additional Paid-In Capital
188.97188.97132.9835.41.1190.87
Retained Earnings
-740.54-760.93-654.35-570.16-422.31-841.21
Comprehensive Income & Other
24.1315.7422.07-11.0916.01-9.8
Total Common Equity
719.46690.67718.61612.81738.46873.66
Minority Interest
13.7111.8820.5310.9832.138.44
Shareholders' Equity
733.16702.56739.14623.8770.56912.09
Total Liabilities & Equity
1,3381,2921,5051,2141,1731,264

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
430.24425.91564.28386.34349.96325.5
Net Cash (Debt)
23.3325.78-98.19-38.31-10.42113.78
Net Cash Growth
------
Net Cash Per Share
0.190.21-0.82-0.33-0.091.07
Filing Date Shares Outstanding
124.69124.69121.79115.87114.37114.37
Total Common Shares Outstanding
124.69124.69121.79115.87114.37114.37
Working Capital
425.01421.78394.49380.07348.33473.91
Book Value Per Share
5.775.545.905.296.467.64
Tangible Book Value
630.08589.44582.09456.72570.02693.81
Tangible Book Value Per Share
5.054.734.783.944.986.07
Machinery
539.39529.8535.61487.94481.86462.27